-
1
-
-
79958065049
-
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary)
-
Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol 2011, 27:124-131.
-
(2011)
Can J Cardiol
, vol.27
, pp. 124-131
-
-
Leiter, L.A.1
Fitchett, D.H.2
Gilbert, R.E.3
-
2
-
-
70349675632
-
Molecular insights and therapeutic targets for diabetic endothelial dysfunction
-
Xu J., Zou M.H. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 2009, 120:1266-1286.
-
(2009)
Circulation
, vol.120
, pp. 1266-1286
-
-
Xu, J.1
Zou, M.H.2
-
3
-
-
4143052506
-
Endothelial progenitor cells: characterization and role in vascular biology
-
Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
-
(2004)
Circ Res
, vol.95
, pp. 343-353
-
-
Urbich, C.1
Dimmeler, S.2
-
4
-
-
33747431983
-
Circulating progenitor cells are reduced in patients with severe lung disease
-
Fadini G.P., Schiavon M., Cantini M., et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006, 24:1806-1813.
-
(2006)
Stem Cells
, vol.24
, pp. 1806-1813
-
-
Fadini, G.P.1
Schiavon, M.2
Cantini, M.3
-
5
-
-
0037180517
-
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures
-
Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
-
(2002)
Circulation
, vol.106
, pp. 2781-2786
-
-
Tepper, O.M.1
Galiano, R.D.2
Capla, J.M.3
-
6
-
-
34447309095
-
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone
-
Sorrentino S.A., Bahlmann F.H., Besler C., et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007, 116:163-173.
-
(2007)
Circulation
, vol.116
, pp. 163-173
-
-
Sorrentino, S.A.1
Bahlmann, F.H.2
Besler, C.3
-
7
-
-
81255158835
-
Vascular disease risk in patients with hypertriglyceridemia: endothelial progenitor cells, oxidative stress, accelerated senescence, and impaired vascular repair
-
Thorin E. Vascular disease risk in patients with hypertriglyceridemia: endothelial progenitor cells, oxidative stress, accelerated senescence, and impaired vascular repair. Can J Cardiol 2011, 27:538-540.
-
(2011)
Can J Cardiol
, vol.27
, pp. 538-540
-
-
Thorin, E.1
-
8
-
-
0035836698
-
An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen
-
Chan K., Han X.D., Kan Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci U S A 2001, 98:4611-4616.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 4611-4616
-
-
Chan, K.1
Han, X.D.2
Kan, Y.W.3
-
9
-
-
58149352893
-
Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease
-
Xue M., Qian Q., Adaikalakoteswari A., et al. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008, 57:2809-2817.
-
(2008)
Diabetes
, vol.57
, pp. 2809-2817
-
-
Xue, M.1
Qian, Q.2
Adaikalakoteswari, A.3
-
10
-
-
77951878150
-
Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart
-
Wang G., Hamid T., Keith R.J., et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010, 121:1912-1925.
-
(2010)
Circulation
, vol.121
, pp. 1912-1925
-
-
Wang, G.1
Hamid, T.2
Keith, R.J.3
-
12
-
-
20544474751
-
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes
-
Kruger A.L., Peterson S., Turkseven S., et al. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 2005, 111:3126-3134.
-
(2005)
Circulation
, vol.111
, pp. 3126-3134
-
-
Kruger, A.L.1
Peterson, S.2
Turkseven, S.3
-
13
-
-
0036279939
-
Heme oxygenase 1 in regulation of inflammation and oxidative damage
-
Yet S.F., Melo L.G., Layne M.D., Perrella M.A. Heme oxygenase 1 in regulation of inflammation and oxidative damage. Methods Enzymol 2002, 353:163-176.
-
(2002)
Methods Enzymol
, vol.353
, pp. 163-176
-
-
Yet, S.F.1
Melo, L.G.2
Layne, M.D.3
Perrella, M.A.4
-
14
-
-
78649703778
-
Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma
-
Kim D.H., Vanella L., Inoue K., et al. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma. Stem Cells Dev 2010, 19:1863-1873.
-
(2010)
Stem Cells Dev
, vol.19
, pp. 1863-1873
-
-
Kim, D.H.1
Vanella, L.2
Inoue, K.3
-
15
-
-
27144457438
-
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms
-
Shibata R., Sato K., Pimentel D.R., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11:1096-1103.
-
(2005)
Nat Med
, vol.11
, pp. 1096-1103
-
-
Shibata, R.1
Sato, K.2
Pimentel, D.R.3
-
16
-
-
62549120373
-
Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin
-
Sambuceti G., Morbelli S., Vanella L., et al. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 2009, 27:399-407.
-
(2009)
Stem Cells
, vol.27
, pp. 399-407
-
-
Sambuceti, G.1
Morbelli, S.2
Vanella, L.3
-
17
-
-
77958153380
-
Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis
-
Lev E.I., Leshem-Lev D., Mager A., et al. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. Eur Heart J 2010, 31:2625-2632.
-
(2010)
Eur Heart J
, vol.31
, pp. 2625-2632
-
-
Lev, E.I.1
Leshem-Lev, D.2
Mager, A.3
-
18
-
-
0031945885
-
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment
-
Desfaits A.C., Serri O., Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 1998, 21:487-493.
-
(1998)
Diabetes Care
, vol.21
, pp. 487-493
-
-
Desfaits, A.C.1
Serri, O.2
Renier, G.3
-
19
-
-
44249095590
-
Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells
-
Kim D.H., Burgess A.P., Li M., et al. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther 2008, 325:833-840.
-
(2008)
J Pharmacol Exp Ther
, vol.325
, pp. 833-840
-
-
Kim, D.H.1
Burgess, A.P.2
Li, M.3
-
20
-
-
42049122627
-
Heme oxygenase: a target gene for anti-diabetic and obesity
-
Abraham N.G., Tsenovoy P.L., McClung J., Drummond G.S. Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des 2008, 14:412-421.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 412-421
-
-
Abraham, N.G.1
Tsenovoy, P.L.2
McClung, J.3
Drummond, G.S.4
|